- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-3ASR Automatic shelf registration
- 5.1 EX-5.1
- 5.2 EX-5.2
- 5.3 EX-5.3
- 23.1 EX-23.1
- 25.1 EX-25.1
- 25.2 EX-25.2
- 25.3 EX-25.3
- 25.4 EX-25.4
- 25.5 EX-25.5
- 25.6 EX-25.6
- 25.7 EX-25.7
- 25.8 EX-25.8
- 25.9 EX-25.9
- 25.10 EX-25.10
- 25.11 EX-25.11
- 25.12 EX-25.12
- 25.13 EX-25.13
- 25.14 EX-25.14
- 25.15 EX-25.15
- 25.16 EX-25.16
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form S-3 of Teva Pharmaceutical Industries Limited of our report dated February 10, 2021 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in Teva Pharmaceutical Industries Limited’s Annual Report on Form 10-K for the year ended December 31, 2020. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Kesselman & Kesselman
Certified Public Accountants (Isr.)
A member firm of PricewaterhouseCoopers International Limited
Tel-Aviv, Israel
October 27, 2021